(Q37909911)

25 August 2017

1 reference

title

Neuroendocrine neoplasms of the gut and pancreas: new insights (English)

1 reference

25 August 2017

0 references

2

Bertram Wiedenmann

0 references

Guido Rindi

object named as

Guido Rindi

series ordinal

1

0 references

publication date

2 August 2011

1 reference

Nature Reviews Endocrinology

25 August 2017

published in

1 reference

25 August 2017

volume

8

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

54-64

1 reference

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Everolimus for advanced pancreatic neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Sunitinib paves the way for targeted therapies in neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Review: the role of neural crest cells in the endocrine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Minireview: Development and differentiation of gut endocrine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Gastroenteropancreatic neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Ultrastructural and biochemical analysis of “undifferentiated” pulmonary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Requirement of Math1 for secretory cell lineage commitment in the mouse intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Nkx2.2 regulates cell fate choice in the enteroendocrine cell lineages of the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Cellular plasticity within the pancreas--lessons learned from development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

The tumor stem cell concept-implications for endocrine tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Thyroid stem cells: lessons from normal development and thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Cancer stem cell hypothesis in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Goblet cell carcinoid of the appendix: a specific type of carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Neurogenin 3 and neurogenic differentiation 1 are retained in the cytoplasm of multiple endocrine neoplasia type 1 islet and pancreatic endocrine tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrine-endocrine neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Well-differentiated pancreatic tumor/carcinoma: insulinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Gastrinoma (duodenal and pancreatic).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Imaging of neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Anatomic and functional imaging of metastatic carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Imaging of carcinoid tumors: spectrum of findings with pathologic and clinical correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Role of video endoscopy in managing small bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Capsule endoscopy: progress update and challenges ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Molecular imaging of neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

First‐line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

A unique heart disease associated with a unique cancer: carcinoid heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Carcinoid heart disease: case and literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Well-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Radioembolization of liver tumors with yttrium-90 microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Radiofrequency ablation of pulmonary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Pulmonary neuroendocrine/carcinoid tumors: a review article

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Molecular markers associated with response to chemotherapy in gastro-entero-pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Preclinical and clinical studies of peptide receptor radionuclide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

90Y-edotreotide for metastatic carcinoid refractory to octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

New medical strategies for midgut carcinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Clinicopathological Features of Pancreatic Endocrine Tumors: A Prospective Multicenter Study in Italy of 297 Sporadic Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Survival From Malignant Digestive Endocrine Tumors in England and Wales: A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Identification of gastroenteropancreatic neuroendocrine cells in normal and neoplastic human tissue with antibodies against synaptophysin, chromogranin A, secretogranin I (chromogranin B), and secretogranin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Pheochromocytomas in Nf1 knockout mice express a neural progenitor gene expression profile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Allelic alterations in well-differentiated neuroendocrine tumors (carcinoid tumors) identified by genome-wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Chromosome 18 deletions are common events in classical midgut carcinoid tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Carcinoid metastasis to the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.120

Imaging of NETs with PET radiopharmaceuticals.

31 March 2020

1 reference

12 December 2020

Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis

1 reference

12 December 2020

High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications.

1 reference

12 December 2020

Targeted ablation of secretin-producing cells in transgenic mice reveals a common differentiation pathway with multiple enteroendocrine cell lineages in the small intestine.

1 reference

12 December 2020

Atypical carcinoid tumors of the lung

1 reference

12 December 2020

Expression of Reg IV and Hath1 in neuroendocrine neoplasms

1 reference

12 December 2020

Basic helix-loop-helix transcription factor profiling of lung tumors shows aberrant expression of the proneural gene atonal homolog 1 (ATOH1, HATH1, MATH1) in neuroendocrine tumors

1 reference

12 December 2020

From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumors

1 reference

12 December 2020

Neuroendocrinomas and neuroendocrine carcinomas: APUD cell system neoplasms and their aberrant secretory activities

1 reference

12 December 2020

Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management

1 reference

12 December 2020

Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases

1 reference

12 December 2020

Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2011.120

1 reference

25 August 2017

1 reference